Manganese threonine chelate—a new enteric contrast agent for MRI: a pilot study on rats

2020 ◽  
Vol 33 (6) ◽  
Author(s):  
Yan Luo ◽  
Hao Yu ◽  
Daoyu Hu ◽  
Jiali Li ◽  
Xuemei Hu ◽  
...  
Keyword(s):  
Pilot Study ◽  
Contrast Agent ◽  
Enteric Contrast

scholarly journals A pilot study of leakage and compartmentalization of the contrast agent Ablavar

2013 ◽  
Vol 15 (S1) ◽  
Author(s):  
Octavia Bane ◽  
Daniel C Lee ◽  
Brandon Benefield ◽  
Michael Markl ◽  
James Carr ◽  
...  
Keyword(s):  
Pilot Study ◽  
Contrast Agent

CE-Iohexol: A Nephroprotective Iodinated Contrast Agent With Cardioprotective Properties - A Pilot Study

2021 ◽  
Vol 28 ◽  
pp. S32-S33
Author(s):  
Elizabeth S. Rowe ◽  
Vernon Rowe ◽  
John A. Hunter ◽  
Michael R. Gralinski ◽  
Liomar A. Neves
Keyword(s):  
Pilot Study ◽  
Contrast Agent ◽  
Iodinated Contrast ◽  
Iodinated Contrast Agent

scholarly journals Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children

2014 ◽  
Vol 45 (6) ◽  
pp. 831-839 ◽  
Author(s):  
Nichanan Ruangwattanapaisarn ◽  
Albert Hsiao ◽  
Shreyas S. Vasanawala
Keyword(s):  
Pilot Study ◽  
Contrast Agent ◽  
Mr Angiography ◽  
Off Label ◽  
3T Mr

scholarly journals Voiding Urosonography with Second-Generation Ultrasound Contrast Agent for Diagnosis of Vesicoureteric Reflux: First Local Pilot Study

2017 ◽  
Vol 5 (2) ◽  
pp. 215-221 ◽  
Author(s):  
Dafina Kuzmanovska ◽  
Aleksandar Risteski ◽  
Margarita Kambovska ◽  
Tase Trpcevski ◽  
Emilija Sahpazova ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Pilot Study ◽  
Contrast Agent ◽  
Second Generation ◽  
Vesicoureteric Reflux ◽  
Ultrasound Contrast Agent ◽  
Pathological Finding ◽  
Voiding Urosonography ◽  
Ultrasound Contrast ◽  
Contrast Enhanced

BACKGROUND: Vesicoureteric reflux (VUR) is an important association of paediatric urinary tract infection (UTI) found in 30-50% of all children presenting with first UTI. Contrast-enhanced voiding ultrasonography (ceVUS) has become an important radiation-free method for VUR detection in children. Its sensitivity in detecting VUR has greatly improved due to the development of the contrast-specific ultrasound techniques and the introduction of the second-generation ultrasound contrast agent, superseding the diagnostic accuracy of standard radiological procedures.AIM: This article aimed to summarise the current literature and discuss the first local pilot study performed in our institution on detection of vesicoureteric reflux by contrast-enhanced voiding ultrasonography with second- generation agent (SonoVue, Bracco, Italy).MATERIAL AND METHODS: Retrospective review of the first 31 ceVUS (24 girls, 7 boys) was presented.  Age range was 2 months to 18 years (mean = 6.4 ± 4.9).RESULTS:  All examinations were well tolerated without any adverse incident. VUR was shown in 20 (64.5%) children in 32/62 (51.6) nephroureteral units (NUUs). In 18 NUUs, VUR was grade II/V, in 11 Grade III/V and in 3 grade IV/V, respectively. Urethra was shown in 19/31 children and in all boys, without pathological finding. In two girls spinning top urethra has been detected. Subsequent urodynamic studies revealed functional bladder problem in both. CONCLUSIONS: Contrast-enhanced voiding urosonography using intravesical second generation ultrasound contrast agent could be recommend  as a valid alternative diagnostic modality for detecting vesicoureteral reflux and evaluation of the distal urinary tract in children, based on its radiation-free, highly efficacious, reliable, and safe characteristics.

scholarly journals A nephroprotective iodinated contrast agent with cardioprotective properties: A pilot study

2021 ◽  
Author(s):  
Elizabeth S. Rowe ◽  
Vernon D. Rowe ◽  
John Hunter ◽  
Michael R. Gralinski ◽  
Liomar A. Neves
Keyword(s):  
Pilot Study ◽  
Contrast Agent ◽  
Iodinated Contrast ◽  
Iodinated Contrast Agent
Sign in / Sign up

Export Citation Format

Share Document